| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/21/2013 | CN103261209A Diphenyl sulfide derivative and pharmaceutical product which contains same as active ingredient |
| 08/21/2013 | CN103261199A Naphthyridine derivative |
| 08/21/2013 | CN103261197A Highly-soluble pyrroloquinoline quinone salt and method for producing same |
| 08/21/2013 | CN103261185A Continuous arycyclic compound |
| 08/21/2013 | CN103260627A Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (gvhd). |
| 08/21/2013 | CN103260612A Treatment of mecp2-ssociated disorders |
| 08/21/2013 | CN103254177A Modulators of atp-binding cassette transporters |
| 08/21/2013 | CN103251863A Chinese medicinal decoction for treating stagnant pathogen of Shaoyang type pleural effusion |
| 08/21/2013 | CN103251843A Medicine for treating dairy cow disease of eating grass and not eating feed and preparation method |
| 08/21/2013 | CN102698181B Chinese medicine preparation containing rhizoma anemarrhenae and used for treating sweating disease and preparation method of same |
| 08/21/2013 | CN102526129B Method for preparing Poria cocos granules by replacing part of auxiliary materials with ultrafine powder |
| 08/21/2013 | CN102026647B Pharmaceutical composition for treating or preventing cancer which induces dendritic cell-like differentiation of monocytes to increase anticancer immune activity |
| 08/21/2013 | CN101910143B Condensed aminodihydrothiazine derivative |
| 08/21/2013 | CN101856363B Application of Bortezomib in preparing drugs for curing POEMS syndrome |
| 08/21/2013 | CN101790517B Inhibitor of binding of s1p1 |
| 08/21/2013 | CN101664553B Stabilization of hypoxia inducible factor (HIF) alpha |
| 08/21/2013 | CN101478966B Compressed preparation |
| 08/21/2013 | CN101050194B Derivative of bicyclo-octanes class, preparation method, and application of medicine |
| 08/20/2013 | US8513293 Methods of treating a hyperproliferative disorder or inhibiting cell growth in a mammal |
| 08/20/2013 | US8513281 Method of treating traumatic brain and spinal cord injuries and other neurogenic conditions using non-steroidal anti-inflammatory drugs and naturally occurring conotoxins |
| 08/20/2013 | US8513279 Quinuclidine derivatives and medicinal compositions containing the same |
| 08/20/2013 | US8513262 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 08/20/2013 | US8513253 α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors |
| 08/20/2013 | US8513237 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 08/20/2013 | US8513027 Method of identifying an inhibitor of the prostanoid EP4 receptor |
| 08/20/2013 | US8512712 Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions |
| 08/20/2013 | US8512693 Self-assembling membranes and related methods thereof |
| 08/20/2013 | CA2569729C Peptidomimetic inhibitors of retroviral proteases and their use as antivirals |
| 08/20/2013 | CA2492333C Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |
| 08/20/2013 | CA2488558C Prevention and reduction of blood loss |
| 08/20/2013 | CA2452417C Compositions comprising the biologicially active peptide ysl |
| 08/19/2013 | CA2827869A1 Therapeutic agent for corneal sensory nerve damage containing semaphorin inhibitor as active ingredient |
| 08/15/2013 | WO2013118136A1 Stable taurine oral composition |
| 08/15/2013 | WO2013117713A1 Reversal of senescence |
| 08/15/2013 | WO2013117008A1 Composition comprising hawthorn and phytosterols |
| 08/15/2013 | US20130212740 Fucosyl transferase gene |
| 08/15/2013 | US20130209459 TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 08/14/2013 | EP2626351A1 Agent for inhibiting expression of lipid metabolism related mrna |
| 08/14/2013 | EP2626349A1 Amine compound and use for same |
| 08/14/2013 | EP2626071A1 Applications of arctigenin in formulating medicines for preventing or treating diseases related to red blood cell reduction |
| 08/14/2013 | EP2624821A1 Combination therapy for the treatment of depression and other non-infectious diseases |
| 08/14/2013 | CN103249726A Acylbenzene derivative |
| 08/14/2013 | CN103249721A Arylamide derivatives as TTX-S blockers |
| 08/14/2013 | CN103249433A Bio-functionalized stimulus-esponsive dissolvable peg-hydrogels |
| 08/14/2013 | CN103249422A Tie2 activator, vascular endothelial growth factor inhibitor, anti-ngiogenic agent, agent for maturing blood vessels, agent for normalizing blood vessels, agent for stabilizing blood vessels, and pharmaceutical composition |
| 08/14/2013 | CN103249407A Combination therapy for the treatment of depression and other non-infectious diseases |
| 08/14/2013 | CN103243086A Method for modifying oligonucleotides, modified oligonucleotides obtained thereby and application of modified oligonucleotides |
| 08/14/2013 | CN103239673A Traditional Chinese medicine composition for preventing and curing sudden death syndrome of cow |
| 08/14/2013 | CN103239567A Traditional Chinese medicine for treating non-hemorrhagic organ injuries |
| 08/14/2013 | CN103239547A Traditional Chinese medicine for treating hernia |
| 08/14/2013 | CN102716334B Chinese medicinal composition for dispelling the cold and removing stasis |
| 08/14/2013 | CN101664551B Stabilization of hypoxia inducible factor (HIF) alpha |
| 08/14/2013 | CN101486682B N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 08/14/2013 | CN101346153B Immunoglobulin G (IGG) concentrate depleted of anti-A and anti-B antibodies and of polyreactive IGGS |
| 08/13/2013 | US8507722 Hepatitis C virus inhibitors |
| 08/13/2013 | US8507550 Treatment for altitudinal hypoxia |
| 08/13/2013 | US8507484 Preventive and/or therapeutic agent for neutrophilic inflammatory diseases |
| 08/13/2013 | US8506958 Methods for treating TWEAK-related conditions |
| 08/13/2013 | US8506945 Polymers with structure-defined functions |
| 08/13/2013 | CA2690753C Sulfonamide compound and crystal thereof |
| 08/13/2013 | CA2580409C Triazole derivative or salt thereof |
| 08/13/2013 | CA2543406C Mutants of human chondromodulin-i (hchm-i) and uses thereof in inhibiting angiogenesis and bone resorption |
| 08/13/2013 | CA2464121C Pregnancy-associated plasma protein-a2 (papp-a2) |
| 08/13/2013 | CA2438513C Modified anti-egfr antibodies with reduced immunogenicity |
| 08/13/2013 | CA2393141C Novel methods for the treatment and prevention of ileus |
| 08/08/2013 | WO2013026989A3 Liposome comprising at least one cholesterol derivative |
| 08/08/2013 | US20130203805 Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylase |
| 08/08/2013 | US20130203767 Treatment of Pulmonary Hypertension |
| 08/08/2013 | US20130202663 Remedy |
| 08/08/2013 | US20130202572 Caffeine-free dietary supplements for increasing energy and methods of administering the same |
| 08/08/2013 | US20130202552 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins |
| 08/08/2013 | US20130199922 Controlling Chemical Reactions by Spectral Chemistry and Spectral Conditioning |
| 08/07/2013 | EP2623505A1 (aza)indolizine derivative and pharmaceutical use thereof |
| 08/07/2013 | CN103237800A Amide derivative and use thereof |
| 08/07/2013 | CN103237794A P2X4 receptor antagonist |
| 08/07/2013 | CN103237554A Follicle-regenerating composition which contains cd36-xpressing connective tissue sheath cells |
| 08/07/2013 | CN103237552A Treating conditions associated with increased eotaxin with 25-hydroxyvitamin D3 |
| 08/07/2013 | CN103237551A Pharmaceutical formulation having neuroprotective activity |
| 08/07/2013 | CN103232381A Peptidomimetic protease inhibitors |
| 08/07/2013 | CN102036962B Combined use of angiogenesis inhibitor and taxane |
| 08/07/2013 | CN101379089B Anti-ilt7 antibody |
| 08/06/2013 | US8504303 System and methods for optimized drug delivery and progression of diseased and normal cells |
| 08/06/2013 | US8501791 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 08/06/2013 | US8501737 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 08/06/2013 | CA2690686C Amine compound and pharmaceutical use thereof |
| 08/06/2013 | CA2609388C Novel piperidine derivative |
| 08/06/2013 | CA2477075C Pharmaceutical and cosmetic compositions comprising plgf-1 |
| 08/06/2013 | CA2388807C Viruses for the treatment of cellular proliferative disorders |
| 08/06/2013 | CA2368213C Specifically targeted catalytic antagonists and uses thereof |
| 08/01/2013 | WO2013111823A1 Method for producing sphingoid base-containing extract |
| 08/01/2013 | WO2013111798A1 Serine racemase inhibitor |
| 08/01/2013 | WO2013111796A1 N-substituted pyrazole derivative |
| 08/01/2013 | WO2013111729A1 Pharmaceutical composition and quasi-drug cosmetic using same |
| 08/01/2013 | WO2013111714A1 Prophylactic or therapeutic agent for bronchial asthma and method for screening same |
| 08/01/2013 | US20130198875 Rna sequence-specific mediators of rna interference |
| 08/01/2013 | US20130196987 Macrocyclic compounds useful as pharmaceuticals |
| 08/01/2013 | US20130196955 Polymorphisms for predicting disease and treatment outcome |
| 08/01/2013 | US20130196863 Method of determining chromatin structure |
| 08/01/2013 | US20130195751 Self-assembed conjugate and use thereof |
| 07/31/2013 | EP2620436A1 Substituted polycyclic carbamoyl pyridone derivative prodrug |